A Phase 2A Trial of DT402 for Autism Spectrum Disorder

Clinical trial NCT07303907 · RECRUITING

Trial details

NCT number: NCT07303907
Sponsor: Definium Therapeutics US, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Autism Spectrum Disorder ASD

Start date: 2025-12-03
Primary completion: 2027-08-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.